nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—mouth—Crohn's disease	0.0259	0.224	CbGeAlD
Rasagiline—BCL2—epithelium—Crohn's disease	0.0151	0.13	CbGeAlD
Rasagiline—BCL2—Ceramide signaling pathway—KSR1—Crohn's disease	0.0147	0.0544	CbGpPWpGaD
Rasagiline—BCL2—smooth muscle tissue—Crohn's disease	0.0145	0.125	CbGeAlD
Rasagiline—BCL2—skin of body—Crohn's disease	0.0143	0.124	CbGeAlD
Rasagiline—BCL2—lymphoid tissue—Crohn's disease	0.0116	0.1	CbGeAlD
Rasagiline—BCL2—digestive system—Crohn's disease	0.0115	0.099	CbGeAlD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—ATG16L1—Crohn's disease	0.0114	0.042	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IL23A—Crohn's disease	0.0088	0.0325	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TNFSF15—Crohn's disease	0.00861	0.0318	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—Crohn's disease	0.00819	0.0303	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—ZFP36L1—Crohn's disease	0.0071	0.0262	CbGpPWpGaD
Rasagiline—BCL2—lymph node—Crohn's disease	0.00654	0.0566	CbGeAlD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—DNMT3A—Crohn's disease	0.00604	0.0223	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD1—Crohn's disease	0.00597	0.0221	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—Crohn's disease	0.00583	0.0215	CbGpPWpGaD
Rasagiline—MAOB—mammalian vulva—Crohn's disease	0.00544	0.047	CbGeAlD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—RIPK2—Crohn's disease	0.0048	0.0177	CbGpPWpGaD
Rasagiline—MAOB—digestive system—Crohn's disease	0.00477	0.0412	CbGeAlD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—SLC11A1—Crohn's disease	0.00476	0.0176	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—IL2RA—Crohn's disease	0.00429	0.0158	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—Crohn's disease	0.00417	0.0154	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—IL3—Crohn's disease	0.00413	0.0153	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—PRDM1—Crohn's disease	0.00403	0.0149	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.00391	0.0144	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TAB1—Crohn's disease	0.00385	0.0142	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.00379	0.014	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—Crohn's disease	0.00378	0.014	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—IL2RA—Crohn's disease	0.00363	0.0134	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00353	0.013	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—SOCS1—Crohn's disease	0.00351	0.013	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNFRSF1B—Crohn's disease	0.00348	0.0129	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00344	0.0127	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—SMAD3—Crohn's disease	0.00341	0.0126	CbGpPWpGaD
Rasagiline—CYP1A2—digestive system—Crohn's disease	0.00339	0.0293	CbGeAlD
Rasagiline—BCL2—C-MYB transcription factor network—MPO—Crohn's disease	0.00338	0.0125	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—SOCS1—Crohn's disease	0.00335	0.0124	CbGpPWpGaD
Rasagiline—Cough increased—Mesalazine—Crohn's disease	0.00333	0.00542	CcSEcCtD
Rasagiline—BCL2—IL-2 Signaling Pathway—IL2RA—Crohn's disease	0.00328	0.0121	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TNFRSF1B—Crohn's disease	0.00327	0.0121	CbGpPWpGaD
Rasagiline—Colitis—Azathioprine—Crohn's disease	0.00321	0.00523	CcSEcCtD
Rasagiline—BCL2—Kit receptor signaling pathway—SOCS1—Crohn's disease	0.00312	0.0115	CbGpPWpGaD
Rasagiline—Neck pain—Mesalazine—Crohn's disease	0.00308	0.00502	CcSEcCtD
Rasagiline—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00308	0.00502	CcSEcCtD
Rasagiline—Stomatitis—Mercaptopurine—Crohn's disease	0.00306	0.00498	CcSEcCtD
Rasagiline—Vaginal inflammation—Mesalazine—Crohn's disease	0.00304	0.00496	CcSEcCtD
Rasagiline—Neoplasm—Azathioprine—Crohn's disease	0.00302	0.00492	CcSEcCtD
Rasagiline—Abnormal dreams—Mesalazine—Crohn's disease	0.00301	0.0049	CcSEcCtD
Rasagiline—Melaena—Mesalazine—Crohn's disease	0.00297	0.00485	CcSEcCtD
Rasagiline—Colitis—Mesalazine—Crohn's disease	0.00292	0.00476	CcSEcCtD
Rasagiline—Vaginal infection—Mesalazine—Crohn's disease	0.00287	0.00468	CcSEcCtD
Rasagiline—Neuropathy—Mesalazine—Crohn's disease	0.00286	0.00466	CcSEcCtD
Rasagiline—Cramps of lower extremities—Mesalazine—Crohn's disease	0.0028	0.00456	CcSEcCtD
Rasagiline—Ecchymosis—Mesalazine—Crohn's disease	0.00275	0.00448	CcSEcCtD
Rasagiline—Mouth ulceration—Mesalazine—Crohn's disease	0.00275	0.00448	CcSEcCtD
Rasagiline—BCL2—EPO signaling pathway—JAK2—Crohn's disease	0.00274	0.0101	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—ICAM1—Crohn's disease	0.00274	0.0101	CbGpPWpGaD
Rasagiline—MAOB—lymph node—Crohn's disease	0.00272	0.0235	CbGeAlD
Rasagiline—BCL2—IL2-mediated signaling events—IL2RA—Crohn's disease	0.00268	0.0099	CbGpPWpGaD
Rasagiline—Hypertonia—Mesalazine—Crohn's disease	0.00267	0.00435	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—Crohn's disease	0.00264	0.00975	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—SMAD3—Crohn's disease	0.00256	0.00945	CbGpPWpGaD
Rasagiline—Immune system disorder—Mercaptopurine—Crohn's disease	0.00254	0.00415	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—TAB1—Crohn's disease	0.00254	0.00939	CbGpPWpGaD
Rasagiline—Gastroenteritis—Mesalazine—Crohn's disease	0.00249	0.00406	CcSEcCtD
Rasagiline—Alopecia—Mercaptopurine—Crohn's disease	0.00249	0.00406	CcSEcCtD
Rasagiline—Deafness—Mesalazine—Crohn's disease	0.00247	0.00403	CcSEcCtD
Rasagiline—Eczema—Mesalazine—Crohn's disease	0.00246	0.00401	CcSEcCtD
Rasagiline—Malnutrition—Mercaptopurine—Crohn's disease	0.00245	0.004	CcSEcCtD
Rasagiline—Eye pain—Mesalazine—Crohn's disease	0.00245	0.00399	CcSEcCtD
Rasagiline—Renal failure acute—Mesalazine—Crohn's disease	0.00239	0.0039	CcSEcCtD
Rasagiline—Libido decreased—Mesalazine—Crohn's disease	0.00238	0.00388	CcSEcCtD
Rasagiline—Dermatitis bullous—Mesalazine—Crohn's disease	0.00231	0.00377	CcSEcCtD
Rasagiline—BCL2—IL-5 Signaling Pathway—JAK2—Crohn's disease	0.00229	0.00846	CbGpPWpGaD
Rasagiline—Delusion—Prednisone—Crohn's disease	0.00228	0.00371	CcSEcCtD
Rasagiline—Arthritis—Mesalazine—Crohn's disease	0.00227	0.0037	CcSEcCtD
Rasagiline—Anaemia—Mercaptopurine—Crohn's disease	0.00227	0.00369	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL3—Crohn's disease	0.00225	0.0083	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—TYK2—Crohn's disease	0.00222	0.00822	CbGpPWpGaD
Rasagiline—Mania—Prednisone—Crohn's disease	0.00221	0.00361	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00221	0.0036	CcSEcCtD
Rasagiline—Osteoarthritis—Mesalazine—Crohn's disease	0.00221	0.0036	CcSEcCtD
Rasagiline—Leukopenia—Mercaptopurine—Crohn's disease	0.00219	0.00358	CcSEcCtD
Rasagiline—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00219	0.00357	CcSEcCtD
Rasagiline—Migraine—Mesalazine—Crohn's disease	0.00218	0.00354	CcSEcCtD
Rasagiline—Affect lability—Mesalazine—Crohn's disease	0.00218	0.00354	CcSEcCtD
Rasagiline—Neuritis—Prednisone—Crohn's disease	0.00216	0.00352	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—HSPA1B—Crohn's disease	0.00215	0.00795	CbGpPWpGaD
Rasagiline—Glaucoma—Prednisone—Crohn's disease	0.00214	0.00349	CcSEcCtD
Rasagiline—Face oedema—Mesalazine—Crohn's disease	0.00213	0.00348	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—Crohn's disease	0.00213	0.00787	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—JAK2—Crohn's disease	0.00212	0.00784	CbGpPWpGaD
Rasagiline—Mood swings—Mesalazine—Crohn's disease	0.00209	0.00341	CcSEcCtD
Rasagiline—Arthralgia—Mercaptopurine—Crohn's disease	0.00209	0.0034	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00207	0.00338	CcSEcCtD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00205	0.00759	CbGpPWpGaD
Rasagiline—Liver function test abnormal—Mesalazine—Crohn's disease	0.00204	0.00332	CcSEcCtD
Rasagiline—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00202	0.00329	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL18—Crohn's disease	0.00197	0.00728	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—JAK2—Crohn's disease	0.00195	0.00719	CbGpPWpGaD
Rasagiline—Skin disorder—Mercaptopurine—Crohn's disease	0.00194	0.00317	CcSEcCtD
Rasagiline—Dysphagia—Mesalazine—Crohn's disease	0.00191	0.00311	CcSEcCtD
Rasagiline—Asthma—Mesalazine—Crohn's disease	0.00191	0.00311	CcSEcCtD
Rasagiline—Influenza—Mesalazine—Crohn's disease	0.00191	0.00311	CcSEcCtD
Rasagiline—Anorexia—Mercaptopurine—Crohn's disease	0.00191	0.00311	CcSEcCtD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—JAK2—Crohn's disease	0.00189	0.00697	CbGpPWpGaD
Rasagiline—Delirium—Prednisone—Crohn's disease	0.00187	0.00305	CcSEcCtD
Rasagiline—Infestation—Azathioprine—Crohn's disease	0.00187	0.00305	CcSEcCtD
Rasagiline—Infestation NOS—Azathioprine—Crohn's disease	0.00187	0.00305	CcSEcCtD
Rasagiline—Angina pectoris—Mesalazine—Crohn's disease	0.00186	0.00303	CcSEcCtD
Rasagiline—Amenorrhoea—Prednisone—Crohn's disease	0.00183	0.00299	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00182	0.00297	CcSEcCtD
Rasagiline—Dysuria—Mesalazine—Crohn's disease	0.00179	0.00291	CcSEcCtD
Rasagiline—BCL2—IL-3 Signaling Pathway—CXCL8—Crohn's disease	0.00178	0.00656	CbGpPWpGaD
Rasagiline—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00178	0.00289	CcSEcCtD
Rasagiline—Arthropathy—Prednisone—Crohn's disease	0.00177	0.00289	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—IFNG—Crohn's disease	0.00177	0.00653	CbGpPWpGaD
Rasagiline—Pollakiuria—Mesalazine—Crohn's disease	0.00176	0.00287	CcSEcCtD
Rasagiline—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00174	0.00284	CcSEcCtD
Rasagiline—Decreased appetite—Mercaptopurine—Crohn's disease	0.00174	0.00283	CcSEcCtD
Rasagiline—Weight decreased—Mesalazine—Crohn's disease	0.00173	0.00282	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00173	0.00282	CcSEcCtD
Rasagiline—Infestation—Mesalazine—Crohn's disease	0.0017	0.00277	CcSEcCtD
Rasagiline—Infestation NOS—Mesalazine—Crohn's disease	0.0017	0.00277	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SMAD3—Crohn's disease	0.0017	0.00628	CbGpPWpGaD
Rasagiline—Depression—Mesalazine—Crohn's disease	0.0017	0.00277	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Crohn's disease	0.0017	0.00627	CbGpPWpGaD
Rasagiline—Haemoglobin—Azathioprine—Crohn's disease	0.00169	0.00275	CcSEcCtD
Rasagiline—BCL2—IL-5 Signaling Pathway—STAT3—Crohn's disease	0.00168	0.00621	CbGpPWpGaD
Rasagiline—Haemorrhage—Azathioprine—Crohn's disease	0.00168	0.00273	CcSEcCtD
Rasagiline—BCL2—Kit receptor signaling pathway—JAK2—Crohn's disease	0.00168	0.0062	CbGpPWpGaD
Rasagiline—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00167	0.00272	CcSEcCtD
Rasagiline—Jaundice—Mesalazine—Crohn's disease	0.00166	0.0027	CcSEcCtD
Rasagiline—Stomatitis—Mesalazine—Crohn's disease	0.00166	0.0027	CcSEcCtD
Rasagiline—Conjunctivitis—Mesalazine—Crohn's disease	0.00166	0.0027	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—SMAD3—Crohn's disease	0.00165	0.0061	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IFNG—Crohn's disease	0.00165	0.00609	CbGpPWpGaD
Rasagiline—Sweating—Mesalazine—Crohn's disease	0.00163	0.00266	CcSEcCtD
Rasagiline—Haematuria—Mesalazine—Crohn's disease	0.00162	0.00265	CcSEcCtD
Rasagiline—BCL2—IL-2 Signaling Pathway—STAT3—Crohn's disease	0.00162	0.00597	CbGpPWpGaD
Rasagiline—Epistaxis—Mesalazine—Crohn's disease	0.00161	0.00262	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.0016	0.0059	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	0.00159	0.00588	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TLR4—Crohn's disease	0.00158	0.00585	CbGpPWpGaD
Rasagiline—Body temperature increased—Mercaptopurine—Crohn's disease	0.00158	0.00258	CcSEcCtD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—STAT3—Crohn's disease	0.00156	0.00575	CbGpPWpGaD
Rasagiline—Haemoglobin—Mesalazine—Crohn's disease	0.00154	0.0025	CcSEcCtD
Rasagiline—Rhinitis—Mesalazine—Crohn's disease	0.00153	0.0025	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—CXCL8—Crohn's disease	0.00153	0.00566	CbGpPWpGaD
Rasagiline—Haemorrhage—Mesalazine—Crohn's disease	0.00153	0.00249	CcSEcCtD
Rasagiline—Immune system disorder—Azathioprine—Crohn's disease	0.00152	0.00247	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—Crohn's disease	0.00152	0.0056	CbGpPWpGaD
Rasagiline—Mediastinal disorder—Azathioprine—Crohn's disease	0.00151	0.00246	CcSEcCtD
Rasagiline—Neuropathy—Prednisone—Crohn's disease	0.00151	0.00246	CcSEcCtD
Rasagiline—Urinary tract disorder—Mesalazine—Crohn's disease	0.00151	0.00246	CcSEcCtD
Rasagiline—Oedema peripheral—Mesalazine—Crohn's disease	0.00151	0.00245	CcSEcCtD
Rasagiline—Chills—Azathioprine—Crohn's disease	0.00151	0.00245	CcSEcCtD
Rasagiline—Connective tissue disorder—Mesalazine—Crohn's disease	0.0015	0.00245	CcSEcCtD
Rasagiline—Urethral disorder—Mesalazine—Crohn's disease	0.0015	0.00244	CcSEcCtD
Rasagiline—Alopecia—Azathioprine—Crohn's disease	0.00148	0.00242	CcSEcCtD
Rasagiline—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00147	0.0024	CcSEcCtD
Rasagiline—Oesophagitis—Prednisone—Crohn's disease	0.00147	0.0024	CcSEcCtD
Rasagiline—Ecchymosis—Prednisone—Crohn's disease	0.00146	0.00237	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—ITGA4—Crohn's disease	0.00143	0.0053	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—STAT3—Crohn's disease	0.00143	0.00528	CbGpPWpGaD
Rasagiline—Eye disorder—Mesalazine—Crohn's disease	0.00143	0.00233	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—DEFA5—Crohn's disease	0.00142	0.00525	CbGpPWpGaD
Rasagiline—Cardiac disorder—Mesalazine—Crohn's disease	0.00142	0.00231	CcSEcCtD
Rasagiline—Hyperkinesia—Prednisone—Crohn's disease	0.0014	0.00229	CcSEcCtD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—Crohn's disease	0.0014	0.00517	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00139	0.00514	CbGpPWpGaD
Rasagiline—Angiopathy—Mesalazine—Crohn's disease	0.00139	0.00226	CcSEcCtD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—STAT3—Crohn's disease	0.00138	0.00511	CbGpPWpGaD
Rasagiline—Immune system disorder—Mesalazine—Crohn's disease	0.00138	0.00225	CcSEcCtD
Rasagiline—Mediastinal disorder—Mesalazine—Crohn's disease	0.00138	0.00225	CcSEcCtD
Rasagiline—Chills—Mesalazine—Crohn's disease	0.00137	0.00224	CcSEcCtD
Rasagiline—Diarrhoea—Mercaptopurine—Crohn's disease	0.00137	0.00223	CcSEcCtD
Rasagiline—Ill-defined disorder—Azathioprine—Crohn's disease	0.00136	0.00221	CcSEcCtD
Rasagiline—Alopecia—Mesalazine—Crohn's disease	0.00135	0.0022	CcSEcCtD
Rasagiline—Thrombophlebitis—Prednisone—Crohn's disease	0.00135	0.0022	CcSEcCtD
Rasagiline—Anaemia—Azathioprine—Crohn's disease	0.00135	0.0022	CcSEcCtD
Rasagiline—Mental disorder—Mesalazine—Crohn's disease	0.00134	0.00218	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—STAT3—Crohn's disease	0.00132	0.00488	CbGpPWpGaD
Rasagiline—Malaise—Azathioprine—Crohn's disease	0.00132	0.00215	CcSEcCtD
Rasagiline—Flatulence—Mesalazine—Crohn's disease	0.00131	0.00214	CcSEcCtD
Rasagiline—Leukopenia—Azathioprine—Crohn's disease	0.00131	0.00213	CcSEcCtD
Rasagiline—Vascular purpura—Prednisone—Crohn's disease	0.00131	0.00213	CcSEcCtD
Rasagiline—Dysgeusia—Mesalazine—Crohn's disease	0.0013	0.00212	CcSEcCtD
Rasagiline—Back pain—Mesalazine—Crohn's disease	0.00129	0.0021	CcSEcCtD
Rasagiline—BCL2—Immune System—ERAP2—Crohn's disease	0.00128	0.00474	CbGpPWpGaD
Rasagiline—Muscle spasms—Mesalazine—Crohn's disease	0.00128	0.00208	CcSEcCtD
Rasagiline—Vomiting—Mercaptopurine—Crohn's disease	0.00127	0.00207	CcSEcCtD
Rasagiline—Injury—Prednisone—Crohn's disease	0.00127	0.00207	CcSEcCtD
Rasagiline—Rash—Mercaptopurine—Crohn's disease	0.00126	0.00206	CcSEcCtD
Rasagiline—Dermatitis—Mercaptopurine—Crohn's disease	0.00126	0.00205	CcSEcCtD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—Crohn's disease	0.00126	0.00465	CbGpPWpGaD
Rasagiline—Tremor—Mesalazine—Crohn's disease	0.00125	0.00203	CcSEcCtD
Rasagiline—Amnesia—Prednisone—Crohn's disease	0.00124	0.00203	CcSEcCtD
Rasagiline—Arthralgia—Azathioprine—Crohn's disease	0.00124	0.00203	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00124	0.00201	CcSEcCtD
Rasagiline—Ill-defined disorder—Mesalazine—Crohn's disease	0.00123	0.00201	CcSEcCtD
Rasagiline—BCL2—Kit receptor signaling pathway—STAT3—Crohn's disease	0.00123	0.00455	CbGpPWpGaD
Rasagiline—Anaemia—Mesalazine—Crohn's disease	0.00123	0.002	CcSEcCtD
Rasagiline—Discomfort—Azathioprine—Crohn's disease	0.00123	0.002	CcSEcCtD
Rasagiline—Purpura—Prednisone—Crohn's disease	0.00121	0.00198	CcSEcCtD
Rasagiline—Malaise—Mesalazine—Crohn's disease	0.0012	0.00196	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—CD4—Crohn's disease	0.0012	0.00443	CbGpPWpGaD
Rasagiline—Cardiac failure—Prednisone—Crohn's disease	0.0012	0.00195	CcSEcCtD
Rasagiline—Vertigo—Mesalazine—Crohn's disease	0.0012	0.00195	CcSEcCtD
Rasagiline—Syncope—Mesalazine—Crohn's disease	0.00119	0.00194	CcSEcCtD
Rasagiline—Leukopenia—Mesalazine—Crohn's disease	0.00119	0.00194	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—Crohn's disease	0.00119	0.0044	CbGpPWpGaD
Rasagiline—Nausea—Mercaptopurine—Crohn's disease	0.00119	0.00194	CcSEcCtD
Rasagiline—Infection—Azathioprine—Crohn's disease	0.00118	0.00193	CcSEcCtD
Rasagiline—Loss of consciousness—Mesalazine—Crohn's disease	0.00117	0.00191	CcSEcCtD
Rasagiline—Osteoarthritis—Prednisone—Crohn's disease	0.00117	0.00191	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00117	0.00191	CcSEcCtD
Rasagiline—Cough—Mesalazine—Crohn's disease	0.00116	0.00189	CcSEcCtD
Rasagiline—Skin disorder—Azathioprine—Crohn's disease	0.00116	0.00189	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CARD9—Crohn's disease	0.00116	0.00428	CbGpPWpGaD
Rasagiline—Affect lability—Prednisone—Crohn's disease	0.00115	0.00188	CcSEcCtD
Rasagiline—Hypertension—Mesalazine—Crohn's disease	0.00115	0.00187	CcSEcCtD
Rasagiline—Psychotic disorder—Prednisone—Crohn's disease	0.00114	0.00186	CcSEcCtD
Rasagiline—Chest pain—Mesalazine—Crohn's disease	0.00113	0.00185	CcSEcCtD
Rasagiline—Arthralgia—Mesalazine—Crohn's disease	0.00113	0.00185	CcSEcCtD
Rasagiline—Anxiety—Mesalazine—Crohn's disease	0.00113	0.00184	CcSEcCtD
Rasagiline—Face oedema—Prednisone—Crohn's disease	0.00113	0.00184	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00113	0.00183	CcSEcCtD
Rasagiline—Discomfort—Mesalazine—Crohn's disease	0.00112	0.00182	CcSEcCtD
Rasagiline—Hypotension—Azathioprine—Crohn's disease	0.00111	0.00182	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00111	0.00411	CbGpPWpGaD
Rasagiline—Dry mouth—Mesalazine—Crohn's disease	0.00111	0.00181	CcSEcCtD
Rasagiline—Mood swings—Prednisone—Crohn's disease	0.00111	0.0018	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—Crohn's disease	0.0011	0.00405	CbGpPWpGaD
Rasagiline—Confusional state—Mesalazine—Crohn's disease	0.0011	0.00178	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00109	0.00177	CcSEcCtD
Rasagiline—Infection—Mesalazine—Crohn's disease	0.00108	0.00176	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—CXCL8—Crohn's disease	0.00107	0.00397	CbGpPWpGaD
Rasagiline—Shock—Mesalazine—Crohn's disease	0.00107	0.00174	CcSEcCtD
Rasagiline—Nervous system disorder—Mesalazine—Crohn's disease	0.00107	0.00174	CcSEcCtD
Rasagiline—Skin disorder—Mesalazine—Crohn's disease	0.00105	0.00172	CcSEcCtD
Rasagiline—Hyperhidrosis—Mesalazine—Crohn's disease	0.00105	0.00171	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IFNG—Crohn's disease	0.00104	0.00384	CbGpPWpGaD
Rasagiline—Anorexia—Mesalazine—Crohn's disease	0.00104	0.00169	CcSEcCtD
Rasagiline—Muscular weakness—Prednisone—Crohn's disease	0.00103	0.00168	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00103	0.00168	CcSEcCtD
Rasagiline—BCL2—Immune System—MADCAM1—Crohn's disease	0.00103	0.00379	CbGpPWpGaD
Rasagiline—Hypotension—Mesalazine—Crohn's disease	0.00101	0.00165	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00099	0.00161	CcSEcCtD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000984	0.00364	CbGpPWpGaD
Rasagiline—Feeling abnormal—Azathioprine—Crohn's disease	0.000983	0.0016	CcSEcCtD
Rasagiline—Insomnia—Mesalazine—Crohn's disease	0.000982	0.0016	CcSEcCtD
Rasagiline—Paraesthesia—Mesalazine—Crohn's disease	0.000975	0.00159	CcSEcCtD
Rasagiline—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000975	0.00159	CcSEcCtD
Rasagiline—Dyspnoea—Mesalazine—Crohn's disease	0.000968	0.00158	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CXCL8—Crohn's disease	0.000966	0.00357	CbGpPWpGaD
Rasagiline—Somnolence—Mesalazine—Crohn's disease	0.000966	0.00157	CcSEcCtD
Rasagiline—Dyspepsia—Mesalazine—Crohn's disease	0.000956	0.00156	CcSEcCtD
Rasagiline—Decreased appetite—Mesalazine—Crohn's disease	0.000944	0.00154	CcSEcCtD
Rasagiline—Body temperature increased—Azathioprine—Crohn's disease	0.000943	0.00154	CcSEcCtD
Rasagiline—Abdominal pain—Azathioprine—Crohn's disease	0.000943	0.00154	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000938	0.00153	CcSEcCtD
Rasagiline—Erectile dysfunction—Prednisone—Crohn's disease	0.000931	0.00152	CcSEcCtD
Rasagiline—Constipation—Mesalazine—Crohn's disease	0.000929	0.00151	CcSEcCtD
Rasagiline—BCL2—Immune System—ICOSLG—Crohn's disease	0.000928	0.00343	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—Crohn's disease	0.000926	0.00342	CbGpPWpGaD
Rasagiline—Weight decreased—Prednisone—Crohn's disease	0.000914	0.00149	CcSEcCtD
Rasagiline—Depression—Prednisone—Crohn's disease	0.000898	0.00146	CcSEcCtD
Rasagiline—Feeling abnormal—Mesalazine—Crohn's disease	0.000895	0.00146	CcSEcCtD
Rasagiline—Acute coronary syndrome—Prednisone—Crohn's disease	0.000888	0.00145	CcSEcCtD
Rasagiline—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000888	0.00145	CcSEcCtD
Rasagiline—Myocardial infarction—Prednisone—Crohn's disease	0.000883	0.00144	CcSEcCtD
Rasagiline—Neuropathy peripheral—Prednisone—Crohn's disease	0.000883	0.00144	CcSEcCtD
Rasagiline—Hypersensitivity—Azathioprine—Crohn's disease	0.000878	0.00143	CcSEcCtD
Rasagiline—Urticaria—Mesalazine—Crohn's disease	0.000863	0.00141	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—Crohn's disease	0.00086	0.00318	CbGpPWpGaD
Rasagiline—Body temperature increased—Mesalazine—Crohn's disease	0.000859	0.0014	CcSEcCtD
Rasagiline—Abdominal pain—Mesalazine—Crohn's disease	0.000859	0.0014	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—NOD1—Crohn's disease	0.000844	0.00312	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DEFA5—Crohn's disease	0.000827	0.00306	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNGR2—Crohn's disease	0.000827	0.00306	CbGpPWpGaD
Rasagiline—Diarrhoea—Azathioprine—Crohn's disease	0.000816	0.00133	CcSEcCtD
Rasagiline—Haemoglobin—Prednisone—Crohn's disease	0.000813	0.00132	CcSEcCtD
Rasagiline—Haemorrhage—Prednisone—Crohn's disease	0.000809	0.00132	CcSEcCtD
Rasagiline—Hallucination—Prednisone—Crohn's disease	0.000805	0.00131	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—Crohn's disease	0.000804	0.00297	CbGpPWpGaD
Rasagiline—Hypersensitivity—Mesalazine—Crohn's disease	0.0008	0.0013	CcSEcCtD
Rasagiline—Connective tissue disorder—Prednisone—Crohn's disease	0.000795	0.0013	CcSEcCtD
Rasagiline—Dizziness—Azathioprine—Crohn's disease	0.000788	0.00128	CcSEcCtD
Rasagiline—Asthenia—Mesalazine—Crohn's disease	0.000779	0.00127	CcSEcCtD
Rasagiline—Pruritus—Mesalazine—Crohn's disease	0.000768	0.00125	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CCR6—Crohn's disease	0.000767	0.00283	CbGpPWpGaD
Rasagiline—Vomiting—Azathioprine—Crohn's disease	0.000758	0.00124	CcSEcCtD
Rasagiline—Eye disorder—Prednisone—Crohn's disease	0.000756	0.00123	CcSEcCtD
Rasagiline—Rash—Azathioprine—Crohn's disease	0.000752	0.00123	CcSEcCtD
Rasagiline—Dermatitis—Azathioprine—Crohn's disease	0.000751	0.00122	CcSEcCtD
Rasagiline—Headache—Azathioprine—Crohn's disease	0.000747	0.00122	CcSEcCtD
Rasagiline—Diarrhoea—Mesalazine—Crohn's disease	0.000743	0.00121	CcSEcCtD
Rasagiline—Angiopathy—Prednisone—Crohn's disease	0.000734	0.0012	CcSEcCtD
Rasagiline—Immune system disorder—Prednisone—Crohn's disease	0.000731	0.00119	CcSEcCtD
Rasagiline—Dizziness—Mesalazine—Crohn's disease	0.000718	0.00117	CcSEcCtD
Rasagiline—Alopecia—Prednisone—Crohn's disease	0.000715	0.00116	CcSEcCtD
Rasagiline—Mental disorder—Prednisone—Crohn's disease	0.000709	0.00115	CcSEcCtD
Rasagiline—Nausea—Azathioprine—Crohn's disease	0.000708	0.00115	CcSEcCtD
Rasagiline—MAOB—Metabolism—PLA2G4F—Crohn's disease	0.000708	0.00262	CbGpPWpGaD
Rasagiline—Malnutrition—Prednisone—Crohn's disease	0.000704	0.00115	CcSEcCtD
Rasagiline—Vomiting—Mesalazine—Crohn's disease	0.000691	0.00113	CcSEcCtD
Rasagiline—Rash—Mesalazine—Crohn's disease	0.000685	0.00112	CcSEcCtD
Rasagiline—Dermatitis—Mesalazine—Crohn's disease	0.000684	0.00111	CcSEcCtD
Rasagiline—Headache—Mesalazine—Crohn's disease	0.00068	0.00111	CcSEcCtD
Rasagiline—BCL2—Immune System—CARD9—Crohn's disease	0.000674	0.00249	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Prednisone—Crohn's disease	0.000653	0.00106	CcSEcCtD
Rasagiline—Anaemia—Prednisone—Crohn's disease	0.000651	0.00106	CcSEcCtD
Rasagiline—Agitation—Prednisone—Crohn's disease	0.000647	0.00105	CcSEcCtD
Rasagiline—Nausea—Mesalazine—Crohn's disease	0.000645	0.00105	CcSEcCtD
Rasagiline—Malaise—Prednisone—Crohn's disease	0.000635	0.00103	CcSEcCtD
Rasagiline—Vertigo—Prednisone—Crohn's disease	0.000633	0.00103	CcSEcCtD
Rasagiline—Syncope—Prednisone—Crohn's disease	0.000631	0.00103	CcSEcCtD
Rasagiline—Loss of consciousness—Prednisone—Crohn's disease	0.000619	0.00101	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000617	0.00228	CbGpPWpGaD
Rasagiline—Convulsion—Prednisone—Crohn's disease	0.00061	0.000994	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—UBE2D1—Crohn's disease	0.000608	0.00225	CbGpPWpGaD
Rasagiline—Hypertension—Prednisone—Crohn's disease	0.000608	0.000991	CcSEcCtD
Rasagiline—MAOB—Metabolism—MTMR3—Crohn's disease	0.000602	0.00222	CbGpPWpGaD
Rasagiline—Arthralgia—Prednisone—Crohn's disease	0.000599	0.000977	CcSEcCtD
Rasagiline—Anxiety—Prednisone—Crohn's disease	0.000597	0.000973	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000595	0.00097	CcSEcCtD
Rasagiline—Discomfort—Prednisone—Crohn's disease	0.000592	0.000965	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—RIPK2—Crohn's disease	0.00059	0.00218	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000586	0.00217	CbGpPWpGaD
Rasagiline—Infection—Prednisone—Crohn's disease	0.000571	0.00093	CcSEcCtD
Rasagiline—Shock—Prednisone—Crohn's disease	0.000565	0.000921	CcSEcCtD
Rasagiline—Nervous system disorder—Prednisone—Crohn's disease	0.000564	0.000918	CcSEcCtD
Rasagiline—Skin disorder—Prednisone—Crohn's disease	0.000558	0.00091	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—RASGRP1—Crohn's disease	0.000556	0.00205	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Prednisone—Crohn's disease	0.000556	0.000905	CcSEcCtD
Rasagiline—Anorexia—Prednisone—Crohn's disease	0.000548	0.000893	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—TAB1—Crohn's disease	0.000544	0.00201	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—Crohn's disease	0.000542	0.002	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NOD2—Crohn's disease	0.000535	0.00198	CbGpPWpGaD
Rasagiline—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000524	0.000853	CcSEcCtD
Rasagiline—Insomnia—Prednisone—Crohn's disease	0.00052	0.000847	CcSEcCtD
Rasagiline—Paraesthesia—Prednisone—Crohn's disease	0.000516	0.000841	CcSEcCtD
Rasagiline—Dyspepsia—Prednisone—Crohn's disease	0.000506	0.000824	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—SOCS1—Crohn's disease	0.000504	0.00186	CbGpPWpGaD
Rasagiline—Decreased appetite—Prednisone—Crohn's disease	0.0005	0.000814	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—Crohn's disease	0.000492	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NOD1—Crohn's disease	0.000492	0.00182	CbGpPWpGaD
Rasagiline—Constipation—Prednisone—Crohn's disease	0.000491	0.000801	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000479	0.00177	CbGpPWpGaD
Rasagiline—Feeling abnormal—Prednisone—Crohn's disease	0.000474	0.000772	CcSEcCtD
Rasagiline—Gastrointestinal pain—Prednisone—Crohn's disease	0.00047	0.000766	CcSEcCtD
Rasagiline—MAOB—Metabolism—FADS1—Crohn's disease	0.000469	0.00173	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000459	0.0017	CbGpPWpGaD
Rasagiline—Urticaria—Prednisone—Crohn's disease	0.000456	0.000744	CcSEcCtD
Rasagiline—Body temperature increased—Prednisone—Crohn's disease	0.000454	0.00074	CcSEcCtD
Rasagiline—Abdominal pain—Prednisone—Crohn's disease	0.000454	0.00074	CcSEcCtD
Rasagiline—BCL2—Immune System—CCR6—Crohn's disease	0.000447	0.00165	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GPX4—Crohn's disease	0.000439	0.00162	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000429	0.00159	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000427	0.00158	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCKR—Crohn's disease	0.000424	0.00157	CbGpPWpGaD
Rasagiline—Hypersensitivity—Prednisone—Crohn's disease	0.000423	0.00069	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000417	0.00154	CbGpPWpGaD
Rasagiline—Asthenia—Prednisone—Crohn's disease	0.000412	0.000672	CcSEcCtD
Rasagiline—BCL2—Immune System—PTPN2—Crohn's disease	0.000408	0.00151	CbGpPWpGaD
Rasagiline—Pruritus—Prednisone—Crohn's disease	0.000407	0.000662	CcSEcCtD
Rasagiline—BCL2—Immune System—RBX1—Crohn's disease	0.000404	0.00149	CbGpPWpGaD
Rasagiline—Diarrhoea—Prednisone—Crohn's disease	0.000393	0.000641	CcSEcCtD
Rasagiline—Dizziness—Prednisone—Crohn's disease	0.00038	0.000619	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CRP—Crohn's disease	0.00038	0.0014	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000368	0.00136	CbGpPWpGaD
Rasagiline—Vomiting—Prednisone—Crohn's disease	0.000365	0.000595	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—TLR4—Crohn's disease	0.000364	0.00135	CbGpPWpGaD
Rasagiline—Rash—Prednisone—Crohn's disease	0.000362	0.00059	CcSEcCtD
Rasagiline—Dermatitis—Prednisone—Crohn's disease	0.000362	0.00059	CcSEcCtD
Rasagiline—Headache—Prednisone—Crohn's disease	0.00036	0.000587	CcSEcCtD
Rasagiline—BCL2—Immune System—UBE2D1—Crohn's disease	0.000354	0.00131	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RIPK2—Crohn's disease	0.000343	0.00127	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ITGA4—Crohn's disease	0.000343	0.00127	CbGpPWpGaD
Rasagiline—Nausea—Prednisone—Crohn's disease	0.000341	0.000556	CcSEcCtD
Rasagiline—BCL2—Immune System—IL3—Crohn's disease	0.000335	0.00124	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RASGRP1—Crohn's disease	0.000324	0.0012	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD79A—Crohn's disease	0.000323	0.00119	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TAB1—Crohn's disease	0.000317	0.00117	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000313	0.00116	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NOD2—Crohn's disease	0.000311	0.00115	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.00031	0.00115	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.00031	0.00115	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SOCS1—Crohn's disease	0.000293	0.00108	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TYK2—Crohn's disease	0.000284	0.00105	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—JAK2—Crohn's disease	0.000271	0.001	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL18—Crohn's disease	0.000264	0.000976	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD4—Crohn's disease	0.000257	0.000948	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000244	0.000901	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL2RA—Crohn's disease	0.000235	0.000867	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000228	0.000843	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—Crohn's disease	0.000221	0.000818	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—Crohn's disease	0.000212	0.000784	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—Crohn's disease	0.000203	0.000752	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TYK2—Crohn's disease	0.000165	0.000611	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000164	0.000605	CbGpPWpGaD
Rasagiline—BCL2—Immune System—JAK2—Crohn's disease	0.000158	0.000583	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNG—Crohn's disease	0.000155	0.000572	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD4—Crohn's disease	0.000149	0.000552	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.000139	0.000515	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—Crohn's disease	0.000139	0.000513	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—Crohn's disease	0.000138	0.00051	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—Crohn's disease	0.000135	0.000499	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—Crohn's disease	0.000118	0.000436	CbGpPWpGaD
Rasagiline—BCL2—Immune System—STAT3—Crohn's disease	0.000116	0.000428	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FADS1—Crohn's disease	0.000109	0.000401	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPX4—Crohn's disease	0.000102	0.000376	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCKR—Crohn's disease	9.82e-05	0.000363	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—Crohn's disease	8.08e-05	0.000299	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.01e-05	0.000259	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.14e-05	0.000227	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—Crohn's disease	3.12e-05	0.000115	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.73e-05	0.000101	CbGpPWpGaD
